Article Details

IRA Capital Completes Sale of Medical Office and Life Science Portfolio to Nuveen for $620.4 Million

Retrieved on: 2021-08-09 22:07:30

Tags for this article:

Click the tags to see associated articles and topics

IRA Capital Completes Sale of Medical Office and Life Science Portfolio to Nuveen for $620.4 Million. View article details on hiswai:

Excerpt

The life science assets have a primary focus on pharmaceutical testing and medical device manufacturing. The portfolio features strong investment- ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up